Microtubule-binding drugs such as CA-4, eribulin, paclitaxel and vinorelbine have all been evaluated for their effects on tumor vasculature (Funahashi et al, 2014; Grisham et al, 2018; Kerbel and Kamen, 2004). Here, CA4 is linked to neoplasm.